CORRECTION article

Front. Pharmacol., 12 April 2022

Sec. Ethnopharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.896418

Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years

  • 1. Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China

  • 2. Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

  • 3. The Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

Article metrics

View details

1

Citations

1,2k

Views

732

Downloads

In the published article, there is an error in the clinical trial registry number and the URL of Clinical Trial Registration. The correct Clinical Trial Registry details are “http://www.chictr.org.cn/showproj.aspx?proj=10829, ChiCTR-OPC-15007030”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

osteonecrosis of femoral head, ARCO stage II, therapeutic effect, risk factor, huo xue tong luo

Citation

He X-M, He M-C, Yang P, Zhang Q-W, Chen Z-Q, He W and Wei Q-S (2022) Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. Front. Pharmacol. 13:896418. doi: 10.3389/fphar.2022.896418

Received

15 March 2022

Accepted

16 March 2022

Published

12 April 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Wei He, ; Qiu-Shi Wei,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics